OptiNose Inc has a consensus price target of $4.2 based on the ratings of 10 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Lake Street, and HC Wainwright & Co. on May 15, 2024, May 15, 2024, and April 29, 2024, respectively. With an average price target of $4.33 between HC Wainwright & Co., Lake Street, and HC Wainwright & Co., there's an implied 308.81% upside for OptiNose Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/15/2024 | Buy Now | 371.7% | HC Wainwright & Co. | Matthew Caufield | → $5 | Reiterates | Buy → Buy | Get Alert |
05/15/2024 | Buy Now | 183.02% | Lake Street | Thomas Flaten | $4 → $3 | Maintains | Buy | Get Alert |
04/29/2024 | Buy Now | 371.7% | HC Wainwright & Co. | Matthew Caufield | → $5 | Reiterates | Buy → Buy | Get Alert |
03/18/2024 | Buy Now | 277.36% | Lake Street | Thomas Flaten | $3 → $4 | Maintains | Buy | Get Alert |
03/18/2024 | Buy Now | 371.7% | HC Wainwright & Co. | Matthew Caufield | → $5 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | Buy Now | 371.7% | HC Wainwright & Co. | Matthew Caufield | → $5 | Initiates | → Buy | Get Alert |
08/21/2023 | Buy Now | 183.02% | Lake Street | Thomas Flaten | → $3 | Initiates | → Buy | Get Alert |
08/11/2023 | Buy Now | 183.02% | Piper Sandler | David Amsellem | $4 → $3 | Maintains | Overweight | Get Alert |
11/14/2022 | Buy Now | 371.7% | BMO Capital | Gary Nachman | $6 → $5 | Maintains | Outperform | Get Alert |
10/21/2022 | Buy Now | 371.7% | Jefferies | Glen Santangelo | → $5 | Assumes | → Buy | Get Alert |
The latest price target for OptiNose (NASDAQ:OPTN) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $5.00 expecting OPTN to rise to within 12 months (a possible 371.70% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for OptiNose (NASDAQ:OPTN) was provided by HC Wainwright & Co., and OptiNose reiterated their buy rating.
There is no last upgrade for OptiNose
There is no last downgrade for OptiNose.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OptiNose, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OptiNose was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
While ratings are subjective and will change, the latest OptiNose (OPTN) rating was a reiterated with a price target of $5.00 to $5.00. The current price OptiNose (OPTN) is trading at is $1.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.